The French drugmaker said it had entered a mandate with an “investment service provider”, with the purchase occurring between ...

Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.

But this year, the risk-taking was noticeably dialled down. Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other foreign stocks. In August, S&P Global Market Intelligence reported that US dividends are set to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Icy Hot, America's go-to topical pain relief brand from, Opella, announced a partnership with Notre Dame Athletics, to serve as the first Official Topical Pain Relief Partner of the University's ...

Sanofi Consumer Healthcare India Ltd share price was down by -0.10% from the previous closing price of ₹4,706.55. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...